Drawing for ALLERVISC

USPTO serial 75439982

ALLERVISC

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
KIM, YONG OH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLERVISC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS, NAMELY, SOLUTIONS FOR USE DURING OPHTHALMIC SURGERYACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2000ABN1ABANDONMENT - EXPRESS MAILED
Apr 22, 2000EX2GSOU EXTENSION 2 GRANTED
Mar 2, 2000EXT2SOU EXTENSION 2 FILED
May 27, 1999EX1GSOU EXTENSION 1 GRANTED
Apr 30, 1999EXT1SOU EXTENSION 1 FILED
Mar 16, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 22, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 1998NPUBNOTICE OF PUBLICATION
Oct 12, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 1998DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance